Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea (OSA)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2012 by University of Athens.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
George S. Stergiou, University of Athens Identifier:
First received: September 11, 2012
Last updated: NA
Last verified: September 2012
History: No changes posted
Subjects referred to a sleep clinic had polysomnography (PSG), clinic BP measurements, 24-hour ABP monitoring and HBP monitoring using a device (Microlife WatchBP HomeN) that allows daytime (3 days, 2 duplicate readings/day) and automated nighttime BP measurement (3 nights, 3 readings/night).

Obstructive Sleep Apnoea

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea

Resource links provided by NLM:

Further study details as provided by University of Athens:

Estimated Enrollment: 50
Study Start Date: February 2012
Estimated Study Completion Date: June 2013
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects referred to a sleep clinic

Inclusion Criteria:

  • Age ≤ 65 years
  • Suspected OSA
  • Treated or untreated for hypertension

Exclusion Criteria:

  • History of cardiovascular disease (heart failure, coronary heart disease, arrhythmia or stroke)
  • History of asthma or chronic obstructive pulmonary disease (FEV1/FVC <70%)
  • History of diabetes mellitus, collagen diseases and sarcoidosis
  • Serum creatinine >1.6 mg/dl, proteinuria
  • Previous treatment with CPAP
  • Pregnancy or menstruation during the study
  • Treatment with steroids, lithium or any other drugs affecting BP
  • Change in antihypertensive treatment(if any) in the last 8 weeks before study entry
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01685736

First University Department of Respiratory Medicine, Sotiria Hospital Recruiting
Athens, Greece, 11527
Contact: Manos Alchanatis, Assoc. Prof. Respir. Medicine    +302107763685      
Principal Investigator: Manos Alchanatis, Assoc. Prof. Respir. Medicine         
Hypertension Center, Third Department of Medicine, University of Athens, Greece Recruiting
Athens, Greece, 11527
Contact: George S Stergiou, MD    +302107763117   
Principal Investigator: George S Stergiou, MD         
Sponsors and Collaborators
University of Athens
  More Information

Responsible Party: George S. Stergiou, Associate Professor of Medicine and Hypertension, University of Athens Identifier: NCT01685736     History of Changes
Other Study ID Numbers: OSA
Study First Received: September 11, 2012
Last Updated: September 11, 2012

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on April 24, 2017